Clinical Trials Logo

Open-angle Glaucoma (OAG) clinical trials

View clinical trials related to Open-angle Glaucoma (OAG).

Filter by:
  • None
  • Page 1

NCT ID: NCT06249152 Recruiting - Glaucoma Clinical Trials

Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients

Start date: April 21, 2024
Phase: Phase 2
Study type: Interventional

Qlaris Phase 2 clinical study investigating the safety, tolerability, and ocular hypotensive efficacy of QLS-111 in combination with latanoprost in open-angle glaucoma (OAG) and/or ocular hypertension (OHT) patients.

NCT ID: NCT02228577 Completed - Clinical trials for Open Angle Glaucoma (OAG)

Safety and Performance Study of the CyPass System Applier Model 241

RePASS
Start date: August 2014
Phase:
Study type: Observational

This is a retrospective chart review of cases in which the CyPass Micro-Stent was implanted using the Model 241 Applier. The objective of this study is to characterize and evaluate the safety of the Model 241 Applier when used for CyPass Micro-Stent implantation.

NCT ID: NCT01318252 Completed - Clinical trials for Ocular Hypertension (OHT)

AL-54478 Proof of Concept Study

Start date: June 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of AL-54478 0.005% compared with Latanoprost 0.005% and AL-54478 Vehicle in patients with open-angle glaucoma or ocular hypertension.

NCT ID: NCT01114893 Completed - Ocular Hypertension Clinical Trials

Travoprost Five Day Posology Study

Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of three concentrations of travoprost ophthalmic solution (Groups A, B and C) administered eight times daily.

NCT ID: NCT01097174 Completed - Clinical trials for Open Angle Glaucoma (OAG)

CyPass Clinical Experience Study

CyCLE
Start date: December 2009
Phase: N/A
Study type: Observational

This study is to evaluate the long-term safety, effectiveness and clinical experience of the CyPass Micro-Stent in patients with glaucoma.